Quick Answer
LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Total Assets of $12.73 million for fiscal year 2025.
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $12.73M | +1011.6% |
| 2024 | $1.15M | -73.4% |
| 2023 | $4.31M | -22.5% |
| 2022 | $5.56M | +9.2% |
| 2021 | $5.09M | -2.6% |
| 2020 | $5.23M | +95.7% |
| 2019 | $2.67M | -38.4% |
| 2018 | $4.34M | +217.0% |
| 2017 | $1.37M | +215.7% |
| 2016 | $433.4K | -27.5% |
| 2015 | $598.0K | +10.9% |
| 2014 | $539.3K | -3.4% |
| 2013 | $558.0K | -68.2% |
| 2012 | $1.75M | +307.9% |
| 2011 | $429.8K | -77.7% |
| 2010 | $1.93M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.43M | +220.4% | +357.2% |
| June 30, 2025 | $1.19M | -55.4% | -21.5% |
| March 31, 2025 | $1.51M | -57.8% | +32.2% |
| December 31, 2024 | $1.15M | -73.4% | -32.5% |
| September 30, 2024 | $1.70M | -67.6% | -36.4% |
| June 30, 2024 | $2.67M | -13.8% | -25.7% |
| March 31, 2024 | $3.59M | -17.1% | -16.7% |
| December 31, 2023 | $4.31M | -22.5% | -17.7% |
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. showed an increase of +1011.6% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, LIXTE BIOTECHNOLOGY HOLDINGS, INC.’s total assets has grown by 559.3% (from $1.93 million to $12.73 million).
- The most recent figure is from LIXTE BIOTECHNOLOGY HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: